vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and Ecovyst Inc. (ECVT). Click either name above to swap in a different company.

Ecovyst Inc. is the larger business by last-quarter revenue ($199.4M vs $134.9M, roughly 1.5× CareTrust REIT, Inc.). On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 34.0%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 18.7%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Ecovyst Inc. is a global sustainable specialty materials provider that develops and manufactures high-performance catalysts and functional additives. Its offerings serve key segments including industrial manufacturing, consumer goods, and environmental protection, helping clients improve operational efficiency and lower carbon emissions across North America, Europe, and Asia-Pacific markets.

CTRE vs ECVT — Head-to-Head

Bigger by revenue
ECVT
ECVT
1.5× larger
ECVT
$199.4M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+21.1% gap
CTRE
55.1%
34.0%
ECVT
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
18.7%
ECVT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
ECVT
ECVT
Revenue
$134.9M
$199.4M
Net Profit
$111.3M
Gross Margin
23.4%
Operating Margin
10.9%
Net Margin
82.5%
Revenue YoY
55.1%
34.0%
Net Profit YoY
113.5%
EPS (diluted)
$0.52
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
ECVT
ECVT
Q4 25
$134.9M
$199.4M
Q3 25
$132.4M
$204.9M
Q2 25
$112.5M
$176.1M
Q1 25
$96.6M
$143.1M
Q4 24
$86.9M
$148.9M
Q3 24
$77.4M
$153.9M
Q2 24
$68.9M
$154.0M
Q1 24
$63.1M
$141.6M
Net Profit
CTRE
CTRE
ECVT
ECVT
Q4 25
$111.3M
Q3 25
$74.9M
$-79.3M
Q2 25
$68.5M
$6.0M
Q1 25
$65.8M
$-3.6M
Q4 24
$52.1M
Q3 24
$33.4M
$14.3M
Q2 24
$10.8M
$8.3M
Q1 24
$28.7M
$1.2M
Gross Margin
CTRE
CTRE
ECVT
ECVT
Q4 25
23.4%
Q3 25
25.4%
Q2 25
22.8%
Q1 25
13.3%
Q4 24
28.9%
Q3 24
29.3%
Q2 24
27.3%
Q1 24
23.5%
Operating Margin
CTRE
CTRE
ECVT
ECVT
Q4 25
10.9%
Q3 25
58.1%
13.8%
Q2 25
61.3%
9.0%
Q1 25
-0.7%
Q4 24
15.1%
Q3 24
43.0%
17.9%
Q2 24
15.1%
14.1%
Q1 24
9.5%
Net Margin
CTRE
CTRE
ECVT
ECVT
Q4 25
82.5%
Q3 25
56.6%
-38.7%
Q2 25
60.9%
3.4%
Q1 25
68.1%
-2.5%
Q4 24
60.0%
Q3 24
43.2%
9.3%
Q2 24
15.6%
5.4%
Q1 24
45.6%
0.9%
EPS (diluted)
CTRE
CTRE
ECVT
ECVT
Q4 25
$0.52
$0.06
Q3 25
$0.35
$-0.69
Q2 25
$0.35
$0.05
Q1 25
$0.35
$-0.03
Q4 24
$0.30
$-0.26
Q3 24
$0.21
$0.12
Q2 24
$0.07
$0.07
Q1 24
$0.22
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
ECVT
ECVT
Cash + ST InvestmentsLiquidity on hand
$198.0M
$197.2M
Total DebtLower is stronger
$894.2M
$392.6M
Stockholders' EquityBook value
$4.0B
$603.4M
Total Assets
$5.1B
$1.3B
Debt / EquityLower = less leverage
0.22×
0.65×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
ECVT
ECVT
Q4 25
$198.0M
$197.2M
Q3 25
$712.5M
$82.0M
Q2 25
$306.1M
$69.6M
Q1 25
$26.5M
$127.5M
Q4 24
$213.8M
$131.4M
Q3 24
$377.1M
$123.5M
Q2 24
$495.1M
$83.3M
Q1 24
$451.2M
$103.1M
Total Debt
CTRE
CTRE
ECVT
ECVT
Q4 25
$894.2M
$392.6M
Q3 25
$893.8M
$854.8M
Q2 25
$1.2B
$856.6M
Q1 25
$822.1M
$859.0M
Q4 24
$396.9M
$860.8M
Q3 24
$396.7M
$862.7M
Q2 24
$671.1M
$862.4M
Q1 24
$595.9M
$866.2M
Stockholders' Equity
CTRE
CTRE
ECVT
ECVT
Q4 25
$4.0B
$603.4M
Q3 25
$4.0B
$607.9M
Q2 25
$3.3B
$692.4M
Q1 25
$2.9B
$698.7M
Q4 24
$2.9B
$700.5M
Q3 24
$2.4B
$729.4M
Q2 24
$1.9B
$717.3M
Q1 24
$1.7B
$711.4M
Total Assets
CTRE
CTRE
ECVT
ECVT
Q4 25
$5.1B
$1.3B
Q3 25
$5.1B
$1.7B
Q2 25
$4.7B
$1.8B
Q1 25
$3.9B
$1.8B
Q4 24
$3.4B
$1.8B
Q3 24
$2.9B
$1.8B
Q2 24
$2.7B
$1.8B
Q1 24
$2.3B
$1.8B
Debt / Equity
CTRE
CTRE
ECVT
ECVT
Q4 25
0.22×
0.65×
Q3 25
0.22×
1.41×
Q2 25
0.35×
1.24×
Q1 25
0.28×
1.23×
Q4 24
0.14×
1.23×
Q3 24
0.16×
1.18×
Q2 24
0.35×
1.20×
Q1 24
0.36×
1.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
ECVT
ECVT
Operating Cash FlowLast quarter
$394.0M
$41.8M
Free Cash FlowOCF − Capex
$22.9M
FCF MarginFCF / Revenue
11.5%
Capex IntensityCapex / Revenue
9.4%
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters
$69.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
ECVT
ECVT
Q4 25
$394.0M
$41.8M
Q3 25
$100.9M
$55.3M
Q2 25
$100.8M
$33.0M
Q1 25
$71.4M
$10.3M
Q4 24
$244.3M
$43.5M
Q3 24
$67.2M
$59.9M
Q2 24
$53.0M
$10.0M
Q1 24
$48.8M
$36.5M
Free Cash Flow
CTRE
CTRE
ECVT
ECVT
Q4 25
$22.9M
Q3 25
$53.2M
Q2 25
$7.8M
Q1 25
$-14.0M
Q4 24
$30.9M
Q3 24
$53.6M
Q2 24
$-9.3M
Q1 24
$19.1M
FCF Margin
CTRE
CTRE
ECVT
ECVT
Q4 25
11.5%
Q3 25
26.0%
Q2 25
4.4%
Q1 25
-9.8%
Q4 24
20.7%
Q3 24
34.9%
Q2 24
-6.1%
Q1 24
13.5%
Capex Intensity
CTRE
CTRE
ECVT
ECVT
Q4 25
9.4%
Q3 25
1.0%
Q2 25
14.4%
Q1 25
16.9%
Q4 24
8.5%
Q3 24
4.1%
Q2 24
12.5%
Q1 24
12.3%
Cash Conversion
CTRE
CTRE
ECVT
ECVT
Q4 25
3.54×
Q3 25
1.35×
Q2 25
1.47×
5.52×
Q1 25
1.08×
Q4 24
4.68×
Q3 24
2.01×
4.21×
Q2 24
4.92×
1.20×
Q1 24
1.70×
29.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

ECVT
ECVT

Industrial Mining Automotive$101.3M51%
Regeneration And Treatment Services$90.0M45%
Other$8.1M4%

Related Comparisons